The small-molecular-weight Rho (stands for Ras homologous) GTPases first identified in Aplysia californica (26) function as molecular switches or regulators in the cells: they are "on" in the GTP-bound form and "off" in the GDP-bound form (for reviews, see references 13, 42, and 43) . In the budding yeast Saccharomyces cerevisiae, five Rho-type GTPases, Rho1p (27) , Rho2p (27) , Rho3p (29) , Rho4p (29) , and Cdc42p (1, 18) , have been identified. Saccharomyces RHO1 is essential for yeast cell viability, and an immunofluorescence microscopic study indicated that Rho1p is localized at the cell periphery in the growth site (budding tip and mother bud neck region), where cortical actin patches are localized, suggesting that Rho1p is involved in the regulation of actin cytoskeleton reorganization and cell wall biosynthesis (44) . In recent years, various proteins, such as Pkc1p (19, 35) , Rom7p (also known as Bem4p) (15) , Bni1p (24) , and the ␤-1,3-glucan synthase putative catalytic subunit (10, 38) , have been identified as downstream targets of Rho1p in S. cerevisiae. These effector proteins function in the maintenance of yeast cell morphology during the cell cycle. Pkc1p, a homolog of mammalian protein kinase C, maintains cell wall integrity through the activation of the mitogen-activated protein kinase cascade; Rom7p/Bem4p is thought to be related to bud emergence, and Bni1p is involved in the regulation of actin cytoskeleton reorganization. The regulation of ␤-1,3-glucan synthesis by Rho1p has also been demonstrated in Schizosaccharomyces pombe (2) .
The fungal cell wall structure, its surface area, and its composition are constantly changing in accordance with fungal cell cycle stages and in response to outside signals (8, 22) . The cell wall consists mainly of ␤-glucans, mannoproteins, and a small amount of chitin, all of which are interconnected, providing cells with their rigidity and protecting them from osmotic pressure (8) . ␤-1,3-Glucan is the major component of the fungal cell wall. The enzyme that synthesizes this polymer, ␤-1,3-glucan synthase (UDP-glucose:1,3-␤-D-glucan 3-␤-D-glucosyltransferase; EC 2.4.1.34), has been purified (16) , and the gene encoding its putative catalytic subunit has been cloned from S. cerevisiae (5, 9, 11, 16, 39) , Aspergillus nidulans (21) , and Candida albicans (31) . The S. cerevisiae ␤-1,3-glucan synthase putative catalytic subunit is encoded by GSC1 and GSC2 (also known as FKS1 and FKS2, respectively), a pair of closely related genes which, when both are disrupted, provoke synthetic lethality. These genes encode proteins of approximately 200 kDa with 16 transmembrane domains, the sizes of which are identical to the molecular weights of the dominant proteins in the purified enzyme (16) . In S. cerevisiae Rho1p was identified as a regulator of ␤-1,3-glucan synthase on the basis of the following observations (10, 30, 38) : the purified ␤-1,3-glucan synthase obtained by product entrapment contains Saccharomyces cerevisiae Rho1p and a ␤-1,3-glucan synthesis defect in rho1 mutants could be restored in vitro by the addition of recombinant Saccharomyces cerevisiae Rho1p.
C. albicans, a dimorphic asexual pathogenic fungus, is a major cause of deep mycoses in immunocompromised patients. The dramatic increase in the number of C. albicans infections during the last two decades has been a result of several factors, including larger numbers of patients being treated with immunosuppressants for organ transplant, being given chemotherapy for cancer and enduring long-term catheterization, taking broad-spectrum antibiotics, and surviving longer in immunologically compromised states. C. albicans has two vegetative growth forms: budding growth, which is similar to that of S. cerevisiae, and hyphal growth, which can be induced by several stimuli, such as high temperature, alkaline pH, the supply of N-acetylglucosamine, and the supply of se-rum. Both morphologies are generally observed in disseminated infections. To overcome the limited efficacies, considerable side effects, and toxicities of existing therapeutic regimens for disseminated candidiasis in particular, the development of drugs with different modes of action against the Candida target is desirable. In C. albicans, only one ␤-1,3-glucan synthase gene (GSC1) has been cloned and no cells containing this disrupted gene could be isolated, suggesting that this gene is essential for growth, which is not the case for S. cerevisiae (31) . For the development of a ␤-1,3-glucan synthase inhibitor specific towards pathogenic fungi, especially towards C. albicans, the identification and characterization of the regulatory component of ␤-1,3-glucan synthase, Rho1, in this fungus would be valuable.
We describe here the isolation and characterization of the RHO1 gene from C. albicans. The identity of Candida albicans RHO1 was confirmed by its ability to complement the growth defect of an S. cerevisiae rho1 deletion mutant. We also showed a direct interaction between Candida albicans Rho1p and a ␤-1,3-glucan synthase putative catalytic subunit, Candida albicans Gsc1p, by ligand overlay and cross-linking studies.
Preparation of anti-Candida albicans Rho1p antiserum. Plasmid pGEX4T-1 (Pharmacia) was used to produce the glutathione S-transferase [GST]-Candida Rho1p (from amino acids 130 to 190) fusion protein [GST-Candida albicans ]. GST-Candida albicans Rho1p (130-190) was produced in E. coli JM109 with 1 mM isopropyl-␤-D-thiogalactopyranoside for 2 h, and the recombinant protein was purified from cell lysates by glutathione Sepharose-4B affinity chromatography according to Pharmacia's protocol. Each of five mice (BALB/c) were immunized with 2.5 mg of purified GST-Candida albicans Rho1p (130-190) five times at 2-week intervals. Western blot (immunoblot) analysis was performed with serum diluted 1:2,000 on a polyvinylidene difluoride (PVDF) membrane (Millipore), goat anti-mouse immunoglobulin G antibody (HϩL) AP-conjugate (Bio-Rad), and an AP-conjugate substrate kit (Bio-Rad).
Membrane preparation and Tergitol NP-40-NaCl treatment. C. albicans ATCC 10231 cells (100 g) were used for the membrane preparation as described in reference 16. Tergitol NP-40-NaCl treatment (30, 32) was done with some modifications. Tergitol NP-40 and NaCl were added to the membrane fraction (50 ml, 4 to 8 mg of protein/ml) at final concentrations of 2% and 2 M, respectively, and the membrane suspension was mixed at room temperature for 3 min. After centrifugation at 100,000 ϫ g for 1 h, the membrane precipitate was resuspended in 50 ml of buffer B (50 mM Tris-Cl [pH 7.5], 1 mM EDTA, 33% glycerol, 1 mM ␤-mercaptoethanol) containing 2 M NaCl and 2% Tergitol NP-40. After centrifugation at 100,000 ϫ g for 1 h, the membrane precipitate was washed three times with buffer B to remove the NaCl and Tergitol NP-40. The washed membrane fraction was resuspended in 20 ml of buffer B and stored at Ϫ80°C.
Partial purification of ␤-1,3-glucan synthase by product entrapment. Product entrapment was carried out as described before (31) . Briefly, a 1/20 volume of 10% CHAPS and 2% cholesteryl hemisuccinate stock solution was added to 1 volume of C. albicans membrane fraction (4 to 8 mg of protein/ml, stored in buffer B) and mixed for 30 min on ice. Guanosine 5Ј-O-(3-thiotriphosphate) (GTP␥S) was added at a final concentration of 5 M. The membrane suspension was centrifuged at 100,000 ϫ g for 1 h, and the supernatant was collected. The pellet was homogenized with buffer B containing 0.4% CHAPS, 0.08% cholesteryl hemisuccinate, and 5 M GTP␥S in half the volume of the original membrane suspension. This homogenate was centrifuged again at 100,000 ϫ g for 1 h. After the addition of UDP-glucose at a final concentration of 5 mM, this combined detergent extract was left at room temperature for 1 h, during which time the ␤-1,3-glucan polymerized. The ␤-1,3-glucan polymer was collected by low-speed centrifugation (5,000 ϫ g, 3 min); the loosely packed white pellet was suspended with buffer B containing 0.4% CHAPS, 0.08% cholesteryl hemisuccinate, and 5 mM UDP-glucose and centrifuged again (5,000 ϫ g, 3 min). This step was repeated four times to remove contaminating proteins. After the last wash, the suspension was ultracentrifuged (100,000 ϫ g, 3 min) and the tightly packed pellet was resuspended in a minimum amount of buffer B containing 0.4% CHAPS and 0.08% cholesteryl hemisuccinate but not 5 mM UDP-glucose. After a 10-min incubation on ice, the mixture was ultracentrifuged again (100,000 ϫ g, 3 min) and the supernatant was collected. This extraction step was repeated a total of three times. When necessary, the entrapment step was repeated for the combined supernatant as described above.
Determination of ␤-1,3-glucan synthesis activity. The reaction conditions were the same as described in reference 16, except that 0.18% phosphatidylcholine, 0.2% Tergitol NP-40, and 0.18% CHAPS were added to achieve higher enzyme activity. In contrast, the addition of bovine serum albumin to this reaction mixture gave minimum activation.
Ligand overlay and GTP binding assays. The ligand overlay and GTP binding assays were performed as previously described (17, 28) with the following modifications. The partially purified ␤-1,3-glucan synthase complex was subjected to SDS-polyacrylamide gel electrophoresis (PAGE) on 5 to 20% gradient gels, and the separated proteins were transferred to a PVDF membrane (Millipore). The proteins on the membrane were denatured by agitating the membrane for 5 min in buffer C (25 mM MES [morpholineethanesulfonic acid]-NaOH [pH 6.5], 0.5 mM MgCl 2 , 0.05 mM ZnCl 2 , 0.05% Triton X-100) containing 6 M guanidium hydrochloride, which was then diluted with an equal volume of buffer C. The denatured proteins on the membrane were renatured by agitating the membrane overnight in phosphate-buffered saline containing 0.1% bovine serum albumin, 0.5 mM MgCl 2 , 0.05 mM ZnCl 2 , 0.1% Triton X-100, 5 mM DTT, 0.1% phosphatidylcholine, and 0.1% CHAPS. The membrane was washed three times with 25 mM Tris-Cl (pH 7.5) containing 1 mM MgCl 2 , 0.1 M NaCl, 0.05% Tween 20, 5 mM DTT, and 2 mM EDTA. The membrane was then reacted at room temperature for 30 min and then at 4°C for 10 min with [
35 S]GTP␥S-labeled recombinant Candida albicans Rho1p, which had been prepared by mixing [ 35 S]GTP␥S (1.25 pmol, 1,000 Ci/mmol; Dupont, NEN) with recombinant Candida albicans Rho1p, partially purified with Q-Sepharose in a buffer containing 8 mM Tris-Cl (pH 8.0), 5 mM MgCl 2 , 1 mM EDTA, 1 mM DTT, and 6 mM phosphatidylcholine at 30°C for 30 min. The reacted membrane was briefly washed four times with 25 mM MES-NaOH (pH 6.5) containing 50 mM NaCl, 5 mM MgCl 2 , and 0.05% Triton X-100. The PVDF membrane was dried, exposed to an imaging plate, and analyzed with a Bio Imaging Analyzer, model BAS1000Mac (Fuji Photo Film Co. Ltd.).
Chemical cross-linking with Candida albicans Rho1p and Candida albicans Gsc1p. For the chemical cross-linking reaction, the ␤-1,3-glucan synthase was purified with a MOPS (morpholinepropanesulfonic acid)-NaOH buffer instead of the Tris-Cl buffer in buffer B for the product entrapment, because the Tris-Cl buffer hinders the reaction of the chemical cross-linking reagent. To the ␤-1,3-glucan synthase complex (approximately 2 mg of protein/ml, 40 l), 4 l of 10 mM EGS [ethylene glycol-bis(succinimidyl succinate); spacer arm, 16.1 Å; Pierce Chemical Co.] in 10% dimethyl sulfoxide was added, and the reaction mixture was incubated at room temperature for 10 min. The mixture (20 l) was then subjected to SDS-PAGE on 5 to 20% gradient gels, and the separated proteins were transferred to a PVDF membrane (Millipore). Western blot analysis was performed with mouse anti-Candida albicans Rho1p antisera or anti-Candida albicans Gsc1p monoclonal antibody 2C2, goat anti-mouse immunoglobulin G antibody (HϩL) AP-conjugate (Bio-Rad), and an AP-conjugate substrate kit (Bio-Rad).
Nucleotide sequence accession number. The sequence of the C. albicans RHO1 gene has been submitted to GenBank as accession number D86430.
RESULTS
Cloning of the RHO1 gene from C. albicans. To clone the RHO1 homolog of C. albicans, we used the PCR method with several primers that were based on the sequence of the S. cerevisiae RHO1 gene, with C. albicans ATCC 10231 genomic DNA as a template. An 87-bp PCR-amplified fragment was obtained with one of the primer combinations (see Materials and Methods), which was then subcloned into pT7Blue TVector, and the DNA sequences of several clones were determined. From the DNA sequence analysis of 10 clones, we found that this 87-bp fragment contained two kinds of sequences that were homologous to either Saccharomyces cerevisiae RHO1 or Saccharomyces cerevisiae RHO3. The putative amino acid sequence of the protein encoded by the Saccharomyces RHO1-homologous fragment shared 28 of 29 residues with amino acids 16 to 44 of Saccharomyces cerevisiae Rho1p. The Saccharomyces cerevisiae RHO3-homologous protein shared 26 of 29 residues with Saccharomyces cerevisiae Rho3p and 23 of 29 residues with Saccharomyces cerevisiae Rho1p. With the Saccharomyces cerevisiae RHO1-homologous fragment as a probe, we performed a genomic Southern hybridization for C. albicans ATCC 10231 genomic DNA digested with restriction enzymes (Fig. 1) . Although there are no EcoRI or XbaI sites in the 87-bp PCR product, two bands were hybridized in both EcoRI-and XbaI-digested DNA. When DNA from C. albicans CAI4 was examined under the same conditions, however, one of the two bands in each EcoRI and XbaI digestion disappeared (data not shown), suggesting that these two bands might have been derived from differences in the restriction sites of each allele. Using this 87-bp fragment as a probe, we screened the C. albicans genomic library by colony hybridization under the same stringency conditions. Of 20,000 colonies examined, one colony strongly hybridized with the probe. This clone contained a plasmid harboring an insert of at least 15 kb. To analyze the sequence of the RHO1-homologous gene within the insert, we first used primers corresponding to part of the 87-bp PCR fragment. The insert was found to have the sequence of the PCR-amplified 87-bp fragment within a 597-nucleotide open reading frame encoding a putative peptide of 22.0 kDa (Fig. 2) . The deduced polypeptide was found to have 198 amino acids, 11 fewer than Saccharomyces cerevisiae Rho1p: 1 amino acid was deleted near the N-terminal portion and 10 were deleted near the C-terminal portion. Nevertheless, the putative amino acid sequence of this open reading frame contained all of the consensus sequences conserved among the Rho-type GTPases (Fig. 3A) (4, 41) , was highly homologous to these GTPases, and was 82.9% identical to Saccharomyces cerevisiae Rho1p (Fig. 3B) . Considering these facts, we named this gene Candida albicans RHO1, the C. albicans homolog of Saccharomyces cerevisiae RHO1.
Complementation of the S. cerevisiae rho1 null mutant by Candida albicans RHO1. To determine whether Candida albicans RHO1 would be a functional homolog of Saccharomyces cerevisiae RHO1, we tested whether Candida albicans RHO1 could rescue a rho1 null mutant of S. cerevisiae. We constructed a plasmid that expressed the Candida albicans RHO1 gene under the control of the Saccharomyces cerevisiae RHO1 promoter and its terminator (pYO-CaRHO1) by inserting the PCR-amplified Candida albicans RHO1 gene into plasmid pYO701, which also contains the TRP1 gene as a marker. S. cerevisiae YOC706, which has a rho1 deletion and harbors a plasmid containing both Saccharomyces cerevisiae RHO1 and URA3, was transformed with pYO-CaRHO1. Several TRP1 ϩ transformants were transferred onto agar plates containing 1 mg of 5-fluoroorotic acid per ml to eliminate the plasmids containing only the Saccharomyces cerevisiae RHO1 gene. Figure 4 shows that the 5-fluoroorotic acid-treated transformants could grow at both 30 and 37°C, as could the control strain with the wild-type Saccharomyces cerevisiae RHO1 gene in place of the Candida albicans RHO1 gene. Homo sapiens RhoA, the human homolog of Saccharomyces cerevisiae RHO1, could complement only at 30°C, as reported previously (37) . This result showed that Candida albicans RHO1 could rescue the rho1 null mutant of S. cerevisiae, suggesting that Candida albicans RHO1 has the same function as Saccharomyces cerevisiae RHO1 in vivo.
Regulation of ␤-1,3-glucan synthesis by Candida albicans Rho1p. Recently Qadota et al. (38) , Drgonova et al. (10) , and Mazur and Baginsky (30) reported that Saccharomyces cerevisiae Rho1p is the regulatory protein of ␤-1,3-glucan synthase. We tested whether Candida albicans Rho1p could regulate ␤-1,3-glucan synthase in the same manner as S. cerevisiae Rho1p does. In S. cerevisiae, treatment with Tergitol NP-40 and NaCl depletes Rho1p from the membrane fraction; when the supernatant and treated membrane fraction are then mixed together, the ␤-1,3-glucan synthase activity is reconstituted (30, 32) . We first tested whether recombinant Candida albicans Rho1p could recover the ␤-1,3-glucan synthetase activity of the Tergitol NP-40-NaCl-treated membrane. The recombinant Candida albicans Rho1p, produced in Sf9 insect cells by using the baculovirus expression system, was solubilized with CHAPS and partially purified by Q-Sepharose column chromatography as described in Materials and Methods. The identity of Candida albicans Rho1p was confirmed by Western blot analysis (Fig. 5B, lane 4) . The C. albicans membrane treated with Tergitol NP-40-NaCl showed almost no ␤-1,3-glucan synthetase activity, but that activity could be reconstituted in the washed membrane by the addition of recombinant Candida albicans Rho1p in the presence of GTP␥S but not in its absence (Fig. 6) . Similarly, we found that Candida albicans Rho1p could also reconstitute the enzyme activity of the treated S. cerevisiae membrane (Fig. 6) . These results indicated that the product of the gene we cloned can function as a regulatory protein of ␤-1,3-glucan synthetase (Rho1p) both in vivo and in vitro.
To make an antibody for immunological characterization of Candida albicans Rho1p, we first tried to produce recombinant Candida albicans Rho1p in E. coli. We tried to produce GST-
FIG. 3. (A)
Amino acid sequence alignment of Candida albicans Rho1p, Saccharomyces cerevisiae Rho1p, and H. sapiens RhoA. Identical amino acids among the three proteins are denoted by asterisks. Boxes indicate the conserved domains among Rho-type GTPases (G1, G2, G3, G4, G5, and the geranylgeranylation site [4, 41] 5A ), suggesting that the N terminus of Candida albicans Rho1p might be toxic in E. coli. We used the purified GST-Candida albicans as an antigen to prepare anti-Candida albicans Rho1p antisera from five mice. Rho GTPases are thought to be anchored in the cytosolic side of the plasma membrane through their C-terminal regions after the posttranslational geranylgeranylation at the cysteine residue (23, 41) . Western blot analysis of the anti-Candida albicans Rho1p antiserum (Fig. 5B, lane 1) detected Candida albicans Rho1p in the membrane fraction, suggesting that Candida albicans Rho1p is localized at the membrane, presumably by interaction with the geranylgeranyl residue. We also examined if Candida albicans Rho1 could be copurified with Candida albicans Gsc1p by product entrapment, as has been observed in S. cerevisiae (38) . Product entrapment is a kind of affinity purification method, and all of the components necessary for ␤-1,3-glucan synthetase activity in vitro are enriched in the sample prepared by this procedure. Generally, one cycle of product entrapment increases the specific activity of an enzyme by more than 300-fold. As shown in Fig. 5B , the partially purified ␤-1,3-glucan synthase complex contained Candida albicans
Rho1p (lane 2). This result indicates that Candida albicans
Rho1p is one of the components of ␤-1,3-glucan synthase in C. albicans.
Ligand overlay and chemical cross-linking. The direct interaction of Candida albicans Rho1p and Candida albicans
Gsc1p was examined by ligand overlay assay. This assay is a powerful tool for identifying the function and ligand binding of proteins separated by SDS-PAGE (17, 28) . Recombinant Candida albicans Rho1p was radiolabeled with [ 35 S]GTP␥S and reacted with the PVDF membrane on which partially purified Candida albicans Gsc1p had been immobilized following the SDS-PAGE separation. Recombinant Candida albicans Rho1p binding was observed at the position of Candida albicans Gsc1p (210 kDa) but not at the positions of the marker proteins (Fig. 7, right panel) . No signal was detected when an uninfected insect cell fraction was used in the same way as recombinant Candida albicans Rho1p (Fig. 7, left panel) . In these experiments, the uninfected Sf9 cell membrane control and recombinant Candida albicans Rho1p were treated in exactly the same way.
We also confirmed the direct interaction between Candida albicans Rho1p and Candida albicans Gsc1p by chemical crosslinking. As shown in Fig. 8 , cross-linker EGS, which has a spacer arm length of 16.1 Å, cross-linked Candida albicans Rho1p with Candida albicans Gsc1p so that Candida albicans Gsc1p became reactive with anti-Candida albicans Rho1p antisera, although the difference in the migrations of Candida albicans Gsc1p cross-linked with Candida albicans Rho1p (210 plus 22 kDa) and Candida albicans Gsc1p alone (210 kDa) was not detectable in the 5 to 20% gradient gels.
Both of these results clearly demonstrate that Candida albicans Rho1p directly interacts with a ␤-1,3-glucan synthase putative catalytic subunit, Candida albicans Gsc1p, and regulates the activity of ␤-1,3-glucan synthase in the same manner as has been shown to occur in S. cerevisiae (10, 30, 38) . 
DISCUSSION
It has been suggested that one function of Rho1p in eukaryotic cells is to regulate morphological changes in the cells such as the reorganization of the cortical cytoskeleton and to control processes such as cell morphogenesis, motility, and cytokinesis (13, 43) . Until recently, many studies have been focused on the roles of Rho1p and other Rho proteins in regulating cytoskeletal rearrangement during the cell cycle and in response to outside stimuli (42) . S. cerevisiae and other fungi have cell walls in addition to the plasma membranes, and cell wall biosynthesis should also be in harmony with any changes in the cytoplasm so that fungi can grow and change their morphologies in response to the outside stimuli. Recently, we and other groups have identified Rho1p as the regulatory component of ␤-1,3-glucan synthase, the enzyme that synthesizes the cell wall ␤-1,3-glucan in S. cerevisiae (10, 30, 38) . This finding links the morphological changes taking place inside the cell with changes in the envelope of the fungal cell.
We cloned the Candida albicans RHO1 gene, the C. albicans homolog of Saccharomyces cerevisiae RHO1, which encodes a small Rho-type GTPase. Rho-type GTPases have been identified in several organisms, such as S. cerevisiae (27) , Schizosaccharomyces pombe (33) , H. sapiens (45) , Caenorhabditis elegans (7), A. californica (26) , Drosophila melanogaster (14) Discopyge ommata (34) , and Canis familiaris (6) . These Rho-type GTPases share the six domains shown in Fig. 3A (4, 41) . The putative amino acid sequence coded for by Candida albicans RHO1 possesses all of these domains and exhibits more than 66.8% identity to all of these GTPases, and especially to S. cerevisiae Rho1p (82.9%). Though in S. cerevisiae, four other Rho-type GTPases in addition to Rho1p have been identified, i.e., Rho2p, Rho3p, Rho4p, and Cdc42p, each of them exhibits less than 55.5% identity to Candida albicans Rho1p (Fig. 3B) . Considering the sequence homology of its encoding protein, we would expect Candida albicans RHO1 to be a homolog of Saccharomyces cerevisiae RHO1 but not of the genes encoding the other GTPases isolated from S. cerevisiae. Candida albicans Rho1p is 11 amino acids smaller than Saccharomyces cerevisiae Rho1p, which is in agreement with its size detected by SDS-PAGE after [ 32 P]ADP ribosylation with exoenzyme C3 (30) . We further characterized Candida albicans Rho1p by focusing on the regulation of ␤-1,3-glucan synthesis. M. S. Kang and E. Cabib showed that the ␤-1,3-glucan synthase of membranes from Hansenula anomala and Neurospora crassa could be dissociated into a soluble fraction and a membrane fraction by Tergitol NP-40-NaCl treatment and that the active component in the soluble fraction could bind GTP or GTP␥S. Furthermore, the Tergitol NP-40-NaCl-treated membrane fraction from Hansenula anomala or N. crassa could be reactivated by the soluble fractions from several other fungi, including S. cerevisiae (20) . Recently Mazur and Baginsky showed that the GTP-binding protein in the soluble fraction is Rho1p in S. cerevisiae (30) . We showed that the C. albicans membrane, when treated with Tergitol NP-40-NaCl in the same way, showed almost no ␤-1,3-glucan synthase activity and that recombinant Candida albicans Rho1p could reactivate the membrane activity in the presence of GTP␥S (Fig. 6 ), indicating that Candida albicans Rho1p is the regulator of ␤-1,3-glucan synthase. Moreover, Candida albicans Rho1p could also reactivate the activity of the S. cerevisiae membrane treated in the same way. Thus, Candida albicans Rho1p could act in the same manner as Saccharomyces cerevisiae Rho1p on ␤-1,3-glucan synthesis both in vivo and in vitro. These observations suggested that ␤-1,3-glucan syntheses of other fungi, such as Han- (Fig. 5B, lane 3) , suggesting that Candida albicans Rho1p is one of the components of the active complex of ␤-1,3-glucan synthase of C. albicans. Candida albicans Rho1p was also shown to be localized in the membrane fraction by immunoblot analysis (Fig. 5B, lane 2) . Rho GTPases were shown to be posttranslationally geranylgeranylated at their C-terminal regions, and this modification facilitates the association of the Rho GTPases with the membrane (23, 41) . The consensus sequence C-␣-␣-L, where ␣ is usually an aliphatic amino acid, is conserved among these GTPases and is also found at the C terminus of Candida albicans Rho1p (Fig. 3A) . These observations indicate that Candida albicans Rho1p is also localized at the plasma membrane.
In addition to ␤-1,3-glucan synthase, several other proteins were identified as potential targets of Rho1p in S. cerevisiae: Pkc1p, a homolog of mammalian protein kinase C (19, 35) ; Bni1p, a protein thought to be involved in cytokinesis (24) ; and Rom7p/Bem4p, related to bud emergence (15) . We showed here that the Candida albicans RHO1 gene could complement the S. cerevisiae rho1 null mutant even at 37°C, suggesting the possibilities that Candida albicans Rho1p takes over all of the cellular functions of Saccharomyces cerevisiae Rho1p in S. cerevisiae and that, in C. albicans, the homologs of these effector proteins function in the rearrangement of the actin cytoskeleton during cell growth and in response to outside stimuli. C. albicans has two vegetative growth forms, budding and hyphal growth; the hyphal growth is induced by several stimuli, such as high temperature, alkaline pH, and the supply of serum. The functions of Candida albicans Rho1p in this dimorphic change with respect to ␤-1,3-glucan synthase regulation and actin cytoskeletal rearrangement remain to be elucidated.
In this study, direct interaction between Candida albicans Rho1p and the ␤-1,3-glucan synthase putative catalytic subunit was clearly shown by the ligand overlay and chemical crosslinking experiments ( Fig. 7 and 8) . The same Candida albicans Rho1p is thought to regulate actin cytoskeletal rearrangement through the interactions with Pkc1p, Bni1p, and Rom7p/ Bem4p homologs in C. albicans.
C. albicans is a major pathogenic fungus in deep mycosis and differs from S. cerevisiae in such characteristics as pathogenicity, asexual dymorphism, and sensitivity to the well-known inhibitor of ␤-1,3-glucan synthase Echinocandin B (3, 25) . Furthermore, Hansenula murakii toxin HM-1, an inhibitor of ␤-1,3-glucan synthase in S. cerevisiae, has no effect on the enzyme in C. albicans. To understand the differences in these phenomena, it is important to fully characterize ␤-1,3-glucan synthase at the molecular level by purifying the enzyme and cloning its regulatory component. Work to determine the interaction domain between the putative catalytic subunit Candida albicans Gsc1p and the regulatory subunit Candida albicans Rho1p and the inhibition mechanisms of Echinocandin B and HM-1 remains for further studies.
Moreover, the conditional complementation of the S. cerevisiae rho1 null mutant by the human homolog RhoA and complete complementation by Candida albicans RHO1 (Fig. 4) (37) suggest a functional difference between the two, although Candida albicans Rho1p is 71.5% identical to H. sapiens RhoA.
In light of this difference, Candida albicans Rho1p might be a good target for antifungal drugs.
